BioSpace News Archive

Fred Hutchinson Cancer Research Center to present updated interim data from ongoing MB-106 Phase 1/2 clinical trial

SOHM, Inc. to take advantage of the FDA converting more prescription Products to the over-the-counter Markets.

Additional Funding and Scientific Expertise Advance Company’s Clinical Development and Efforts Towards Commercialization

ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today reported financial results for its fiscal first quarter 2021 and provided an overview of recent progress and accomplishments.

MannKind Corporation reported financial results for the quarter ended March 31, 2021.

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that four abstracts will be presented from the KER-050 and ALK2 hematology programs at the 26th Annual Congress of the European Hematology Association

Cash and Cash Equivalents of $36.6M, More Than Sufficient to Fund Completion of the Current Clinical Trials of Lead Drug Candidate, Seclidemstat

Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today reported its financial results for the first quarter ended March 31, 2021.

Ascentage Pharma announced that according to the latest semi-annual index review results announced by MSCI, a leading provider of index services and analytics, Ascentage Pharma has been selected as a constituent stock of the MSCI China Small Cap Index, effective after the market closes on Thursday, May 27, 2021.

Oncology Pharma Inc. Oncology Pharma, Inc. has submitted its initial application to the NASDAQ to begin the process of moving the listing from the Pink Sheets to the Capital Markets Tier of the NASDAQ Exchange.